Skip to main content

2016 | OriginalPaper | Buchkapitel

10. Nanomedicine and Nanotechnology for Medicine

verfasst von : Patrick Boisseau

Erschienen in: Nanosciences and Nanotechnology

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Nanomedicine is a new field of research and industrial development which aims to use nano-objects for therapeutic purposes. Through miniaturisation, labs-on-chips can improve the performance of medical analysis and diagnosis, while biosensors become less invasive, hence better tolerated or implanted. With the development of nanoscale contrast agents, clinical imaging benefits from better resolution. In the field of therapy, nanocarriers can transport medicines right up to the sick tissue within the organism, while metal nanoparticles can be used for localised destruction of tumours. The possibility of combining diagnosis and therapy by means of these nano-objects (theranostics) also offers hope of improving medical practice generally. Likewise, the controlled combination of stem cells and biomaterials should lead to a new form of regenerative medicine, able to regenerate and repair damaged or destroyed tissue in vivo. This chapter deals precisely with these developments made possible by nanomedicine, discussing the relevant ethical problems which arise also for conventional medicine. It ends with a discussion of the industrial prospects, describing some of the many clinical trials now under way and the promise of innovative drugs for the benefit of the patient.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Fußnoten
1
It is common practice to refer to the combined system of the nanocarrier and the drug it transports as the nanodrug.
 
Literatur
2.
Zurück zum Zitat V. Poher, C.P. Allier, J.G. Coutard, L. Herve, J.M. Dinten, Lens free in-line holographic detection of bacteria, in Advanced Microscopy Techniques II. Proceedings of SPIE, vol. 8086 (2011) V. Poher, C.P. Allier, J.G. Coutard, L. Herve, J.M. Dinten, Lens free in-line holographic detection of bacteria, in Advanced Microscopy Techniques II. Proceedings of SPIE, vol. 8086 (2011)
5.
Zurück zum Zitat A.E. Colvin, H. Jiang, Increased in vivo stability and functional lifetime of an implantable glucose sensor through platinum catalysis. J. Biomed. Mater. Res. 101A, 1274–1282 (2013). \(\copyright \) 2013, Wiley A.E. Colvin, H. Jiang, Increased in vivo stability and functional lifetime of an implantable glucose sensor through platinum catalysis. J. Biomed. Mater. Res. 101A, 1274–1282 (2013). \(\copyright \) 2013, Wiley
6.
Zurück zum Zitat P.D. Rakowska, M.G. Ryadnov, Nano-enabled biomarker discovery and detection. Biomark. Med. 5, 387–96 (2011)CrossRef P.D. Rakowska, M.G. Ryadnov, Nano-enabled biomarker discovery and detection. Biomark. Med. 5, 387–96 (2011)CrossRef
7.
Zurück zum Zitat F.J. Picard, M.G. Bergeron, Rapid molecular theranostics in infectious diseases. Drug Discov. Today 7, 1092–1101 (2002)CrossRef F.J. Picard, M.G. Bergeron, Rapid molecular theranostics in infectious diseases. Drug Discov. Today 7, 1092–1101 (2002)CrossRef
8.
Zurück zum Zitat M.L. Etheridge, S.A. Campbell, A.G. Erdman, L. Haynes, S.M. Wolf, J. McCullough, The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed.: Nanotechnol. Biol. Med. 9, 1–14 (2013)CrossRef M.L. Etheridge, S.A. Campbell, A.G. Erdman, L. Haynes, S.M. Wolf, J. McCullough, The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed.: Nanotechnol. Biol. Med. 9, 1–14 (2013)CrossRef
9.
Zurück zum Zitat E. Martinez, E. Engel, J.A. Planell, J. Samitier, Annals of Anatomy (Anatomischer Anzeiger) 191, 126–135 (2009)CrossRef E. Martinez, E. Engel, J.A. Planell, J. Samitier, Annals of Anatomy (Anatomischer Anzeiger) 191, 126–135 (2009)CrossRef
Metadaten
Titel
Nanomedicine and Nanotechnology for Medicine
verfasst von
Patrick Boisseau
Copyright-Jahr
2016
DOI
https://doi.org/10.1007/978-3-319-19360-1_10